McKesson

361 articles with McKesson

• McKesson Designated by CMS as 2023 Qualified Clinical Data Registry

  2/15/2023

  For the seventh consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.

• McKesson Corporation Declares Quarterly Dividend - January 26, 2023

  1/26/2023

  The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock.

• McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

  12/28/2022

  McKesson Corporation will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023.

• McKesson Corporation Declares Quarterly Dividend

  10/27/2022

  The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock.

• McKesson Opens Its Most Technologically Advanced Healthcare Distribution Center in Jeffersonville, Ohio

  10/26/2022

  McKesson Corporation has opened a new state-of-the-art pharmaceutical distribution center in Jeffersonville, Ohio, centrally located between Cincinnati and Columbus.

• McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health

  9/29/2022

  McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.

• McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer

  9/13/2022

  McKesson Corporation announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer.

• McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share

  7/25/2022

  The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter.

• McKesson ideaShare Conference Draws Attendees From More Than 2,100 Independent Pharmacies to First In-Person Conference Since 2019

  7/12/2022

  2022 Conference Developed by McKesson and Health Mart Focuses on “Charting the Future of Community Pharmacy”.

• McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research

  6/23/2022

  Proposed joint venture aims to expand clinical research services to improve cancer treatment options for patients.

• McKesson Reports Fiscal 2022 Fourth-Quarter Results

  5/5/2022

  McKesson Corporation has released its fiscal 2022 fourth-quarter financial results.

• 

  Life Sciences Industry has Eyes on Texas' Innovation Corridor

  5/4/2022

  Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.

• McKesson Declares Quarterly Dividend - Apr 28, 2022

  4/28/2022

  The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.

• McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date

  4/7/2022

  McKesson Corporation announced that it has closed the transaction announced in November 2021 to sell its UK businesses to AURELIUS.

• McKesson’s Board of Directors Elects W. Roy Dunbar as New Director

  4/1/2022

  McKesson Corporation announced that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022.

• McKesson Designated by CMS as 2022 Qualified Clinical Data Registry

  2/8/2022

  For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.

• McKesson Declares Quarterly Dividend - Jan 27, 2022

  1/27/2022

  The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.

• McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors

  1/18/2022

  McKesson Corporation announced that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022.

• McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference

  12/29/2021

  McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2022 financial results after market close on Wednesday, February 2, 2022.

• McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH

  12/20/2021

  McKesson Corporation announced that it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH.